Extended Data Table 1. A lesion segregation based test for oncogenic selection.
Strain | Gene | Mutation | Mutation count | Odds ratio | P-value | Known driver |
---|---|---|---|---|---|---|
C3H | Braf | 6:37548568_A/T | 151 | 2.13 | 5.77x10-6 | Yes |
C3H | Hras | 7:145859242_T/C | 81 | 2.67 | 6.88x10-6 | Yes |
C3H | Hras | 7:145859242_T/A | 65 | 1.02 | 1 | Yes |
C3H | Intronic Fmnl1 | 11:105081902_A/C | 44 | 1.03 | 1 | No |
C3H | Intergenic | 9:73125689_G/C | 42 | 1.13 | 1 | No |
C3H | Egfr | 11:14185624_T/A | 34 | 3.87 | 1.23x10-4 | Yes |
CAST | Braf | 6:37451282_A/T | 42 | 1.41 | 0.338 | Yes |
Recurrently mutated sites in both C3H and CAST with sufficient estimated power to detect oncogenic selection through biased strand retention analysis (required >33 C3H recurrences or >41 CAST recurrences). Odds ratio values >1 indicate the predicted correlation of driver mutation and Watson/Crick strand retention in tumours with the candidate driver mutation, but not for those without the mutation. The Fisher’s exact test P-value is shown after Bonferroni correction. Known driver indicates the mutation or its orthologous change has previously been implicated as a driver of hepatocellular carcinoma6. The CAST 6:37451282_A/T mutation is orthologous to the C3H 6:37548568_A/T mutation.